Related Experiment Video

Updated: Aug 14, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

The potential for gene-targeted radiation therapy of cancers

Igor G Panyutin1, Ronald D Neumann

  • 1Nuclear Medicine Department, Clinical Center, NIH, Bethesda, MD 20892-1180, USA. igorp@helix.nih.gov

Trends in Biotechnology
|August 30, 2005
PubMed

Insights

Researchers are developing gene-targeted radiation therapy using Auger-emitting radionuclides attached to DNA-binding oligonucleotides. This approach aims to selectively target cancer cell genomes for improved cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiochemistry

Background:

  • Targeted cancer therapy is a key focus in oncology, driven by advances in understanding cancer genetics and cell signaling.
  • Current targeted therapies primarily involve pharmaceutical chemistry to disrupt cancer cell survival pathways.
  • Radiotherapy aims for selective targeting of radiation effects to tumor cells.

Purpose of the Study:

  • To explore a novel approach for gene-targeted radiation therapy.
  • To utilize the unique properties of Auger-emitting radionuclides for cancer treatment.
  • To develop a method for delivering radiation directly to cancer cell genomes.

Main Methods:

  • Attaching radionuclides that decay by the Auger process to oligonucleotide carrier-molecules.
  • Designing oligonucleotides capable of forming triplex DNA structures.
  • Targeting specific DNA sequences within the human cancer cell genome.

Main Results:

  • Demonstrated the feasibility of creating a gene-targeted radiation therapy.
  • Leveraged Auger electron emitters for localized DNA damage within cancer cells.
  • Oligonucleotide-triplex formation enables precise targeting of genomic sequences.

Conclusions:

  • This strategy offers a promising new avenue for targeted cancer treatment.
  • Gene-targeted radiation therapy has the potential to enhance treatment selectivity and efficacy.
  • Further research into oligonucleotide-DNA interactions and radionuclide delivery is warranted.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...